Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)
Recruiting · NCT04197921 · Registry updated 2026-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs) | Chemically-Induced Disorders, Narcotic-Related Disorders, Substance Use Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-06-26 | NCT04197921 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| InSightec | 28 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tampa General Hospital | Tampa | United States | 128 |
| University of Maryland, Baltimore | Baltimore | United States | 32 |
| Weill Cornell Medicine | New York | United States | 122 |
| West Virginia University: Rockefeller Neuroscience Institute | Morgantown | United States | 1 |